American College of Cardiology Mar 29 2026 Older patients with coronary artery disease scheduled for transcatheter aortic valve replacement (TAVR) had comparable outcomes regardless of whether they underwent percutaneous coronary intervention (PCI) before TAVR, according to findings from the PRO-TAVI study presented at the American College of Cardiology's Annual Scientific Session (ACC.26). TAVR is a minimally invasive procedure in which a new aortic valve is delivered via a catheter, most